{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:50:49Z","timestamp":1784224249280,"version":"3.55.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Chronic obstructive pulmonary disease (COPD) is a heterogeneous condition without effective disease modifying therapies. Identification of novel inflammatory endotype markers such as extracellular vesicles (EVs), which are important intercellular messengers carrying microRNA (miRNA), may enable earlier diagnosis and disease stratification for a targeted treatment approach. Our aim was to identify differentially expressed EV miRNA in the lungs of COPD patients compared with healthy ex-smokers and determine whether they can help define inflammatory COPD endotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>EV miRNA were isolated and sequenced from ex-smoking COPD patients and healthy ex-smoker bronchoalveolar lavage fluid. Results were validated with RT-qPCR and compared to differential inflammatory cell counts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Expression analysis identified five upregulated miRNA in COPD (miR-223-3p, miR-2110, miR-182-5p, miR-200b-5p and miR-625-3p) and three downregulated miRNA (miR-138-5p, miR-338-3p and miR-204-5p), all with a log2 fold change of &amp;gt;1\/\u22121, FDR &amp;lt; 0.05. These miRNAs correlated with disease defining characteristics such as FEF 25\u201375% (a small airways disease measure) and DLCO% (a surrogate measure of emphysema). Receiver operator curve analysis demonstrated miR-2110, miR-223-3p, and miR-182-5p showed excellent combinatory predictive ability (AUC 0.91, <jats:italic>p<\/jats:italic> &amp;lt; 0.0001) in differentiating between health and mild COPD. Furthermore, miR-223-3p and miR-338-3p correlated with airway eosinophilia and were able to distinguish \u201cpure eosinophilic\u201d COPD from other airway inflammatory subtypes (AUC 0.94 and 0.85, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This is the first study to identify differentially expressed miRNA in COPD bronchoalveolar lavage fluid EVs. These findings suggest specific lung derived EV miRNA are a strong predictor of disease presence even in mild COPD. Furthermore, specific miRNA correlated with inflammatory cell numbers in COPD, and may have a role in defining inflammatory endotypes for future treatment stratification.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1039702","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T06:08:48Z","timestamp":1671084528000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD"],"prefix":"10.3389","volume":"9","author":[{"given":"Hannah","family":"Burke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doriana","family":"Cellura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Ostridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mirella","family":"Spalluto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl J.","family":"Staples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom M. A.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"B1","year":"2020","journal-title":"Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030.","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"B3","article-title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, 2019 Report.","year":"2018"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(15)60647-X","article-title":"Early chronic obstructive pulmonary disease: definition, assessment, and prevention.","volume":"385","author":"Rennard","year":"2015","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.chest.2020.11.018","article-title":"Interrelationships among small airways dysfunction, neutrophilic inflammation, and exacerbation frequency in COPD.","volume":"159","author":"Day","year":"2021","journal-title":"Chest."},{"key":"B6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease.","volume":"138","author":"Barnes","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/thoraxjnl-2017-210408","article-title":"Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.","volume":"73","author":"Mayhew","year":"2018","journal-title":"Thorax."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1700853","DOI":"10.1183\/13993003.00853-2017","article-title":"Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort.","volume":"50","author":"Kim","year":"2017","journal-title":"Eur Respir J."},{"key":"B10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/longacting \u03b2-2 agonist efficacy in COPD.","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1905248","article-title":"Benralizumab for the prevention of COPD exacerbations.","volume":"381","author":"Criner","year":"2019","journal-title":"New Engl J Med."},{"key":"B12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function.","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell."},{"key":"B13","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3389\/fimmu.2018.00924","article-title":"Extracellular vesicle: an emerging mediator of intercellular crosstalk in lung inflammation and injury.","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1183\/09031936.03.00041703","article-title":"Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid.","volume":"22","author":"Admyre","year":"2003","journal-title":"Eur Respir J."},{"key":"B15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses.","volume":"9","author":"Thery","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs.","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.gpb.2018.06.001","article-title":"Genome-wide MicroRNA expression profiles in COPD: early predictors for cancer development.","volume":"16","author":"Keller","year":"2018","journal-title":"Genomics Proteomics Bioinformat."},{"key":"B19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/crj.12194","article-title":"Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease.","volume":"10","author":"Wang","year":"2016","journal-title":"Clin Respir J."},{"key":"B20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/thoraxjnl-2011-201395","article-title":"Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility.","volume":"67","author":"Takahashi","year":"2012","journal-title":"Thorax."},{"key":"B21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1164\/rccm.201209-1697OC","article-title":"Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The multi-ethnic study of atherosclerosis chronic obstructive pulmonary disease study.","volume":"188","author":"Thomashow","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1164\/rccm.201901-0214OC","article-title":"Dynamics of IFN-\u03b2 responses during respiratory viral infection. Insights for therapeutic strategies.","volume":"201","author":"Watson","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12931-021-01755-3","article-title":"Dysregulation of COVID-19 related gene expression in the COPD Lung.","volume":"22","author":"Watson","year":"2021","journal-title":"Respir Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12931-016-0402-z","article-title":"Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases.","volume":"17","author":"Ostridge","year":"2016","journal-title":"Respir Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","article-title":"An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.","volume":"185","author":"Meyer","year":"2012","journal-title":"Am J Respir Crit Care Med."},{"key":"B26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis.","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells."},{"key":"B27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/cells8080773","article-title":"An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis.","volume":"8","author":"Sol\u00e9","year":"2019","journal-title":"Cells."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3892\/or.2017.5600","article-title":"A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: an integrated study of 1,110 cases.","volume":"37","author":"Xiong","year":"2017","journal-title":"Oncol Rep."},{"key":"B29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/ncrna5040051","article-title":"Small RNA species and microRNA profiles are altered in severe asthma nanovesicles from broncho alveolar lavage and associate with impaired lung function and inflammation.","volume":"5","author":"Francisco-Garcia","year":"2019","journal-title":"Non Coding RNA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e12043","DOI":"10.1002\/jev2.12043","article-title":"RNA packaging into extracellular vesicles: an orchestra of RNA-binding proteins?","volume":"10","author":"Fabbiano","year":"2020","journal-title":"J Extracell Vesicles."},{"key":"B31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2147\/COPD.S99547","article-title":"Microparticles in sputum of COPD patients: a potential biomarker of the disease?","volume":"11","author":"Lacedonia","year":"2016","journal-title":"Int J Chronic Obstruct Pulmon Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.rmed.2017.04.014","article-title":"Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation.","volume":"132","author":"Tan","year":"2017","journal-title":"Respir Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1002\/mgg3.990","article-title":"MiR-182-5p enhances in vitro neutrophil infiltration in Kawasaki disease.","volume":"7","author":"Li","year":"2019","journal-title":"Mol Genet Genomic Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41467-017-00032-6","article-title":"Disruption of the C\/EBPalpha-miR-182 balance impairs granulocytic differentiation.","volume":"8","author":"Wurm","year":"2017","journal-title":"Nat Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0208777","DOI":"10.1371\/journal.pone.0208777","article-title":"microRNA-2110 functions as an onco-suppressor in neuroblastoma by directly targeting Tsukushi.","volume":"13","author":"Zhao","year":"2018","journal-title":"PLoS One."},{"key":"B36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1139\/bcb-2018-0141","article-title":"MicroRNA-204-5p suppresses IL6-mediated inflammatory response and chemokine generation in HK-2 renal tubular epithelial cells by targeting IL6R.","volume":"97","author":"Li","year":"2019","journal-title":"Biochem Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.4049\/jimmunol.181.3.2189","article-title":"IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.","volume":"181","author":"Fielding","year":"2008","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/thoraxjnl-2011-200089","article-title":"Gene expression networks in COPD: microRNA and mRNA regulation.","volume":"67","author":"Ezzie","year":"2012","journal-title":"Thorax."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1183\/09031936.00091513","article-title":"MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD.","volume":"43","author":"Molina-Pinelo","year":"2014","journal-title":"Eur Respir J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"PA4998","DOI":"10.1183\/13993003.congress-2018.PA4998","article-title":"Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma.","volume":"52","author":"Roffel","year":"2018","journal-title":"Eur Respir J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bjorl.2020.05.020","article-title":"MicroRNA-223-3p regulates allergic inflammation by targeting INPP4A.","volume":"87","author":"Zhou","year":"2021","journal-title":"Braz J Otorhinolaryngol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"198.5","DOI":"10.1016\/j.cellsig.2015.05.013","article-title":"Control of B cell activation and migration by PI 3-kinase: role of inositol polyphosphate 4-phosphatases.","volume":"196","author":"Marshall","year":"2016","journal-title":"J Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.arbres.2019.09.020","article-title":"Eosinophilic COPD patients display a distinctive serum miRNA profile from asthma and non-eosinophilic COPD.","volume":"56","author":"Asensio","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease.","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1164\/rccm.201708-1684LE","article-title":"Blood eosinophilia neither reflects tissue eosinophils nor worsens clinical outcomes in chronic obstructive pulmonary disease.","volume":"197","author":"Turato","year":"2017","journal-title":"Am J Respir Crit Care Med."},{"key":"B46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/2040622315609251","article-title":"Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.","volume":"7","author":"George","year":"2016","journal-title":"Therap Adv Chronic Dis."},{"key":"B47","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3109\/00365513.2011.602422","article-title":"Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations.","volume":"71","author":"Sennels","year":"2011","journal-title":"Scand J Clin Lab Invest."},{"key":"B48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000221902","article-title":"Sputum IL-5 concentration is associated with a sputum eosinophilia and attenuated by corticosteroid therapy in COPD.","volume":"78","author":"Bafadhel","year":"2009","journal-title":"Respir Int Rev Thorac Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jaci.2012.11.039","article-title":"Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients.","volume":"131","author":"Lev\u00e4nen","year":"2013","journal-title":"J Allergy Clin Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1164\/rccm.201503-0558OC","article-title":"Altered exosomal RNA profiles in bronchoalveolar lavage from lung transplants with acute rejection.","volume":"192","author":"Gregson","year":"2015","journal-title":"Am J Respir Crit Care Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1039702\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T06:08:57Z","timestamp":1671084537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1039702\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":50,"alternative-id":["10.3389\/fmed.2022.1039702"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1039702","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"1039702"}}